• Return to Headlines

Five Prime Thera Shares Down 55.5% Since SmarTrend's Sell Call (FPRX)

By Amy Schwartz

SmarTrend identified a Downtrend for Five Prime Thera (NASDAQ:FPRX) on November 7th, 2017 at $30.30. In approximately 10 months, Five Prime Thera has returned 55.47% as of today's recent price of $13.49.

Over the past year, Five Prime Thera has traded in a range of $12.52 to $48.87 and is now at $13.49, 8% above that low. The 200-day and 50-day moving averages have moved 1.44% lower and 1.21% lower over the past week, respectively.

Five Prime Therapeutics, Inc. provides clinical stage biotechnology services. The Company offers innovative proteins, antibody therapeutics, and drugs for oncology and immunology diseases. Five Prime Therapeutics serves customers in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Five Prime Thera.

Log in and add Five Prime Thera (FPRX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights five prime thera

Ticker(s): FPRX